Back to the main directory
Company Analysis / Equity
- Morningstar | Digital Realty Closes 2018 With Lackluster Quarter; Maintaining $112 FVE by Morningstar
- Morningstar | EA Posts Weak 3Q as Battlefield Disappoints; Apex Legends and Anthem Launches Increase in Importance. See Updated Analyst Note from 06 Feb 2019 by Morningstar
- Morningstar | Software and Sensors? Xerox's Investor Day Lays Out Revenue Opportunities; Maintain $27.50 FVE by Morningstar
- The Market Missed the Boat With Wide-Moat Rated Emerson’s Fiscal 4Q Results by Morningstar
- Agco Continues Margin Expansion, but Our Long-Term View Remains Unchanged; Maintaining FVE by Morningstar
- Agco's Margin Expansion Continues Despite Higher Material Costs and Strong Competition by Morningstar
- We Maintain Our Fair Value Estimate as Nordea Reports Full-Year 2018 Results by Morningstar
- Morningstar | Novartis Focuses More on Core Drugs as Alcon and Some Generic Assets Are Scheduled for Divestment by Morningstar
- Nordea's Full-Year Profits Up Marginally, Although Operational Results Disappoint by Morningstar
- EssilorLuxottica, a Wide-Moat Leader in the Global Optical Industry, Is Well Positioned For Growth by Morningstar
- Westjet Looks to Stick the Landing on 2019 Revenue Initiatives; Slightly Raising Our FVE by Morningstar
- Lilly Posts Solid 4Q and Long-Term Outlook Looks Solid, but 2019 Guidance Is Slightly Weak by Morningstar
- Morningstar | Lilly Posts Solid 4Q and Long-Term Outlook Looks Solid, but 2019 Guidance Is Slightly Weak by Morningstar
- Plains Benefits From Wide Differentials, Reports Good Fourth Quarter by Morningstar
- Markel Reports Tough 4Q; Book Value Per Share Declines 4% in 2018 by Morningstar
- Morningstar | Mr. Market Overlooked Wide-Moat Emerson's Strong Fiscal First-Quarter Results and Outlook by Morningstar
- Colder-Than-Normal Weather Benefits AmeriGas' Quarterly Results; Long-Term Thesis Intact by Morningstar
- Having Spurned Potential Acquirers, Arconic Aims To Accomplish a Gradual Turnaround by Morningstar
- Colder-Than-Normal Weather Helps AmeriGas' Fiscal 1Q Results by Morningstar
- Morningstar | Having Spurned Potential Acquirers, Arconic Aims To Accomplish a Gradual Turnaround by Morningstar
- Morningstar | The Market Missed the Boat With Wide-Moat Rated Emerson’s Fiscal 1Q Results by Morningstar
- Morningstar | Lowering Our Myriad FVE to $32.50 Due to Near-Term GeneSight Issues by Morningstar
- Unicharm's Growth Decelerates on High Hurdle; Fundamentals Remain Healthy by Morningstar
- Near-Term Issues With Myriad's GeneSight Raise Questions on Execution; Lowering FVE to $32.50 by Morningstar
- Daimler Reports Headline Numbers, 2018 Results Mixed, Full Release Expected Feb. 7 by Morningstar